These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 27835661)

  • 1. Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.
    Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
    PLoS One; 2016; 11(11):e0165933. PubMed ID: 27835661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults.
    Hsu DY; Brieva J; Silverberg NB; Silverberg JI
    J Invest Dermatol; 2016 Jul; 136(7):1387-1397. PubMed ID: 27039263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.
    Hsu DY; Brieva J; Silverberg NB; Paller AS; Silverberg JI
    J Am Acad Dermatol; 2017 May; 76(5):811-817.e4. PubMed ID: 28285784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).
    Velasco-Tirado V; Alonso-Sardón M; Cosano-Quero A; Romero-Alegría Á; Sánchez-Los Arcos L; López-Bernus A; Pardo-Lledías J; Belhassen-García M
    PLoS One; 2018; 13(6):e0198582. PubMed ID: 29912947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in Thailand.
    Dilokthornsakul P; Sawangjit R; Inprasong C; Chunhasewee S; Rattanapan P; Thoopputra T; Chaiyakunapruk N
    J Postgrad Med; 2016; 62(2):109-14. PubMed ID: 27089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Antoon JW; Goldman JL; Lee B; Schwartz A
    Pediatr Dermatol; 2018 Mar; 35(2):182-187. PubMed ID: 29315761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
    Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
    Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea.
    Yang MS; Lee JY; Kim J; Kim GW; Kim BK; Kim JY; Park HW; Cho SH; Min KU; Kang HR
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):690-695.e2. PubMed ID: 31614216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases.
    Davis RL; Gallagher MA; Asgari MM; Eide MJ; Margolis DJ; Macy E; Burmester JK; Selvam N; Boscarino JA; Cromwell LF; Feigelson HS; Kuntz JL; Pawloski PA; Penfold RB; Raebel MA; Sridhar G; Wu A; La Grenade LA; Pacanowski MA; Pinheiro SP
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):684-92. PubMed ID: 25914229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study.
    Martín-Merino E; de Abajo FJ; Gil M
    Eur J Clin Pharmacol; 2015 Jun; 71(6):759-766. PubMed ID: 25939709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.
    Frey N; Jossi J; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    J Invest Dermatol; 2017 Jun; 137(6):1240-1247. PubMed ID: 28202399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
    Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
    J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of 30-day readmission in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cross-sectional database study.
    Guzman AK; Zhang M; Kwatra SG; Kaffenberger BH
    J Am Acad Dermatol; 2020 Feb; 82(2):303-310. PubMed ID: 31542405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
    Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
    J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.